Cartilix, maker of tissue repair treatments, sells to Biomet
Cartilix, a Foster City, Calif.-based biotech firm that makes substances capable of repairing human tissues in joints, has sold to Biomet, an Indiana-based seller of tools and products used to help surgeons, according to PE Hub. Neither company disclosed financial terms. Cartilix previously received $6.5 million in first-round venture funding from De Novo Ventures.
Next Story: Google to buy mobile advertising network AdMob for $750 million
Previous Story: Founder Collective fund rounds up Flickr, LiveOps co-founders and $40 million
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.